SERS-based immunoassay using gold-patterned array chips for rapid and sensitive detection of dual cardiac biomarkers. Issue 22 (25th September 2019)

• Record Type: Journal Article
• Authors: Cheng, Ziyi; Wang, Rui; Xing, Yanlong; Zhao, Linlu; Choo, Jaebum; Yu, Fabiao
• Is Part Of: Analyst. Volume 144:Issue 22(2019)
• Page Start: 6533
• Page End: 6540
• Publication Date: 2019-09-25
• Subjects: Chemistry, Analytic -- Periodicals; 543
• DOI: 10.1039/c9an01260e
• Languages: English
• ISSNs: 0003-2654

Abstract

Abstract : A gold-patterned array platform has been developed for the ultrasensitive SERS-based detection of cTnI and CK-MB. Abstract : Cardiac troponin I (cTnI) and creatine kinase-MB (CK-MB) are important diagnostic biomarkers for acute myocardial infarction (AMI). Many efforts have been undertaken to develop highly sensitive detection methods for the quantitative analysis of these dual targets. However, current immunoassay methods are inadequate for accurate measurement of cTnI and CK-MB, due to their limited detection sensitivity. Thus, there is still an urgent demand for a new technique that will enable ultrahigh sensitive detection of these biomarkers. In this study, we developed a surface-enhanced Raman scattering (SERS)-based sandwich immunoassay platform for the ultrasensitive detection of cTnI and CK-MB. In this study, a monoclonal-antibody-immobilized gold-patterned chip was used as a SERS active template. Target samples and polyclonal-antibody-conjugated Au@Ag core–shell nanoparticles were then added. Using this SERS platform, the concentration of biomarkers could be quantified by monitoring the characteristic Raman peak intensity of Raman reporter molecules. Under optimized conditions, the limits of detection (LODs) were estimated to be 8.9 pg mL −1 and 9.7 pg mL −1 for cTnI and CK-MB, respectively. Thus, the proposed SERS-based immunoassay has great potential to be an effective diagnostic tool for the rapid and accurate detection of cTnI and CK-MB.